145 related articles for article (PubMed ID: 23001375)
1. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.
Ritchie RH; Love JE; Huynh K; Bernardo BC; Henstridge DC; Kiriazis H; Tham YK; Sapra G; Qin C; Cemerlang N; Boey EJ; Jandeleit-Dahm K; Du XJ; McMullen JR
Diabetologia; 2012 Dec; 55(12):3369-81. PubMed ID: 23001375
[TBL] [Abstract][Full Text] [Related]
2. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
3. Enhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling.
Call JA; Chain KH; Martin KS; Lira VA; Okutsu M; Zhang M; Yan Z
Circ Heart Fail; 2015 Jan; 8(1):188-97. PubMed ID: 25504759
[TBL] [Abstract][Full Text] [Related]
4. Guan Xin Dan Shen formulation protects
Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
Yang G; Zhang Q; Dong C; Hou G; Li J; Jiang X; Xin Y
J Cell Physiol; 2024 Feb; 239(2):e31149. PubMed ID: 38308838
[TBL] [Abstract][Full Text] [Related]
6. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G
Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943
[TBL] [Abstract][Full Text] [Related]
7. Diabetic cardiomyopathy - Zinc preventive and therapeutic potentials by its anti-oxidative stress and sensitizing insulin signaling pathways.
Cai L; Tan Y; Watson S; Wintergerst K
Toxicol Appl Pharmacol; 2023 Oct; 477():116694. PubMed ID: 37739320
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol Prevents Diabetic Cardiomyopathy by Increasing Nrf2 Expression and Transcriptional Activity.
Wang G; Song X; Zhao L; Li Z; Liu B
Biomed Res Int; 2018; 2018():2150218. PubMed ID: 29721501
[TBL] [Abstract][Full Text] [Related]
9. Dual roles of myocardial mitochondrial AKT on diabetic cardiomyopathy and whole body metabolism.
Chen YH; Ta AP; Chen Y; Lee HC; Fan W; Chen PL; Jordan MC; Roos KP; MacGregor GR; Yang Q; Edwards RA; Li J; Wang PH
Cardiovasc Diabetol; 2023 Oct; 22(1):294. PubMed ID: 37891673
[TBL] [Abstract][Full Text] [Related]
10. CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis.
Wang LF; Li Q; Wen K; Zhao QH; Zhang YT; Zhao JL; Ding Q; Guan XH; Xiao YF; Deng KY; Xin HB
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958991
[TBL] [Abstract][Full Text] [Related]
11. Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation.
Gopal K; Karwi QG; Tabatabaei Dakhili SA; Wagg CS; Zhang L; Sun Q; Saed CT; Panidarapu S; Perfetti R; Ramasamy R; Ussher JR; Lopaschuk GD
Cardiovasc Diabetol; 2023 Mar; 22(1):73. PubMed ID: 36978133
[TBL] [Abstract][Full Text] [Related]
12. Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice.
Qiu Y; Buffonge S; Ramnath R; Jenner S; Fawaz S; Arkill KP; Neal C; Verkade P; White SJ; Hezzell M; Salmon AHJ; Suleiman MS; Welsh GI; Foster RR; Madeddu P; Satchell SC
Diabetologia; 2022 May; 65(5):879-894. PubMed ID: 35211778
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 3-kinase (PI3K(p110alpha)) directly regulates key components of the Z-disc and cardiac structure.
Waardenberg AJ; Bernardo BC; Ng DCH; Shepherd PR; Cemerlang N; Sbroggiò M; Wells CA; Dalrymple BP; Brancaccio M; Lin RCY; McMullen JR
J Biol Chem; 2011 Sep; 286(35):30837-30846. PubMed ID: 21757757
[TBL] [Abstract][Full Text] [Related]
14. The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes.
Liu D; Xing R; Zhang Q; Tian X; Qi Y; Song H; Liu Y; Yu H; Zhang X; Jing Q; Yan C; Han Y
Exp Mol Med; 2023 Sep; 55(9):2025-2038. PubMed ID: 37658156
[TBL] [Abstract][Full Text] [Related]
15. The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damage.
Zhang C; Zhang L; Chen S; Feng B; Lu X; Bai Y; Liang G; Tan Y; Shao M; Skibba M; Jin L; Li X; Chakrabarti S; Cai L
PLoS One; 2013; 8(12):e82287. PubMed ID: 24349248
[TBL] [Abstract][Full Text] [Related]
16. Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism.
Foukas LC; Bilanges B; Bettedi L; Pearce W; Ali K; Sancho S; Withers DJ; Vanhaesebroeck B
EMBO Mol Med; 2013 Apr; 5(4):563-71. PubMed ID: 23483710
[TBL] [Abstract][Full Text] [Related]
17. Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2-knockout mice.
Huang S; Wang J; Men H; Tan Y; Lin Q; Gozal E; Zheng Y; Cai L
J Cell Mol Med; 2021 Jul; 25(14):6828-6840. PubMed ID: 34053181
[TBL] [Abstract][Full Text] [Related]
18. PI3K(p110α) as a determinant and gene therapy for atrial enlargement in atrial fibrillation.
Ezeani M; Prabhu S
Mol Cell Biochem; 2023 Mar; 478(3):471-490. PubMed ID: 35900667
[TBL] [Abstract][Full Text] [Related]
19. Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model.
Târtea G; Popa-Wagner A; Sfredel V; Mitran SI; Dan AO; Țucă AM; Preda AN; Raicea V; Țieranu E; Cozma D; Vătășescu R
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396795
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus.
Alobaid SM; Alshahrani RM; Alonazi AS; Alrasheed NM; Alamin MA; Alshammari TK; Bin Dayel AF; Elnagar DM; Alotaibi RR; Almuthnabi LA; Almasud DH; Al-Ammar SE; Almadhi SO; Almalke RA; Aldamri NT; Alghibiwi HK; Alkhelb DA; Alrasheed NM
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
